SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-23-034917
Filing Date
2023-10-23
Accepted
2023-10-23 16:25:01
Documents
17
Period of Report
2023-10-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arqt-20231019.htm   iXBRL 8-K 40046
2 EX-1.1 exhibit11-8xk.htm EX-1.1 220788
3 EX-4.1 exhibit41-8xk.htm EX-4.1 107281
4 EX-5.1 exhibit51-8xk.htm EX-5.1 25966
8 image_01a.jpg GRAPHIC 49249
9 image_0a.jpg GRAPHIC 20696
  Complete submission text file 0001628280-23-034917.txt   703528

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arqt-20231019.xsd EX-101.SCH 1889
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arqt-20231019_lab.xml EX-101.LAB 25156
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arqt-20231019_pre.xml EX-101.PRE 13038
11 EXTRACTED XBRL INSTANCE DOCUMENT arqt-20231019_htm.xml XML 2865
Mailing Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361
Business Address 3027 TOWNSGATE ROAD SUITE 300 WESTLAKE VILLAGE CA 91361 805-418-5006
Arcutis Biotherapeutics, Inc. (Filer) CIK: 0001787306 (see all company filings)

IRS No.: 812974255 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39186 | Film No.: 231340233
SIC: 2834 Pharmaceutical Preparations